Product
Norovirus-specific T-cell therapy
1 clinical trial
3 indications
Indication
viral infectionIndication
Hematopoietic Stem Cell TransplantationIndication
Primary Immunodeficiency Disorders (PID)Clinical trial
Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised HostsStatus: Recruiting, Estimated PCD: 2025-08-30